Resultado da Busca
19 de fev. de 2024 · 1 Colorectal Cancer: Executive Summary. 1.1 The colorectal cancer market will grow to $21.8B by 2031, at a compound annual growth rate of 3.3%. 1.2 Combination therapies and immunotherapies for ...
29 de nov. de 2023 · Wed, Nov 29, 2023, 5:01 PM 9 min read. The total metastatic HER2-positive breast cancer market size in the 7MM was estimated to be nearly USD 2.6 billion in 2022, which is expected to show ...
24 de set. de 2021 · Thelansis’s “Relapsed or Refractory Metastatic Colorectal Cancer Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under ...
20 de abr. de 2024 · Colorectal cancer is the third most common diagnosis and cause of cancer-related death in both sexes in the United States.[1] Worldwide, the condition remains the third most common malignancy but is second only to lung cancer in its mortality rate.[2] Incidence rates have been decreasing in Western countries, mostly due to the widespread use of colonoscopy screening. However, the condition's ...
The disease epidemiology covered in the report provides historical as well as forecasted Metastatic Castration-Resistant Prostate Cancer (mCRPC) epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.
Metastatic Colorectal Cancer (mCRC) epidemiology report gives a thorough understanding of the Metastatic Colorectal Cancer (mCRC) by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis.
This section focusses on the rate of uptake of the potential drugs recently launched in the Colorectal Cancer market or expected to get launched in the market during the study period 2019-2032. The analysis covers Colorectal Cancer market uptake by drugs; patient uptake by therapies; and sales of each drug. This helps in understanding the drugs ...
